» Articles » PMID: 26026863

Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy

Abstract

Cardiovascular magnetic resonance (CMR) with extensive late gadolinium enhancement (LGE) is a novel marker for increased risk for sudden death (SD) in patients with hypertrophic cardiomyopathy (HC). Small focal areas of LGE confined to the region of right ventricular (RV) insertion to ventricular septum (VS) have emerged as a frequent and highly visible CMR imaging pattern of uncertain significance. The aim of this study was to evaluate the prognostic significance of LGE confined to the RV insertion area in patients with HC. CMR was performed in 1,293 consecutive patients with HC from 7 HC centers, followed for 3.4 ± 1.7 years. Of 1,293 patients (47 ± 14 years), 134 (10%) had LGE present only in the anterior and/or inferior areas of the RV insertion to VS, occupying 3.7 ± 2.9% of left ventricular myocardium. Neither the presence nor extent of LGE in these isolated areas was a predictor of adverse HC-related risk, including SD (adjusted hazard ratio 0.82, 95% confidence interval 0.45 to 1.50, p = 0.53; adjusted hazard ratio 1.16/10% increase in LGE, 95% confidence interval 0.29 to 4.65, p = 0.83, respectively). Histopathology in 20 HC hearts show the insertion areas of RV attachment to be composed of a greatly expanded extracellular space characterized predominantly by interstitial-type fibrosis and interspersed disorganized myocyte patterns and architecture. In conclusion, LGE confined to the insertion areas of RV to VS was associated with low risk of adverse events (including SD). Gadolinium pooling in this region of the left ventricle does not reflect myocyte death and repair with replacement fibrosis or scarring.

Citing Articles

Amyloids and the Heart: An Update.

Triposkiadis F, Briasoulis A, Xanthopoulos A J Clin Med. 2024; 13(23).

PMID: 39685666 PMC: 11642274. DOI: 10.3390/jcm13237210.


Deep learning of echocardiography distinguishes between presence and absence of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.

Akita K, Kusunose K, Haga A, Shimomura T, Kosaka Y, Ishiyama K Echo Res Pract. 2024; 11(1):23.

PMID: 39396969 PMC: 11472433. DOI: 10.1186/s44156-024-00059-8.


Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies.

Del Franco A, Ruggieri R, Pieroni M, Ciabatti M, Zocchi C, Biagioni G JACC Adv. 2024; 3(10):101214.

PMID: 39246577 PMC: 11380395. DOI: 10.1016/j.jacadv.2024.101214.


Certainties and Uncertainties of Cardiac Magnetic Resonance Imaging in Athletes.

Szabo L, Brunetti G, Cipriani A, Juhasz V, Graziano F, Hirschberg K J Cardiovasc Dev Dis. 2022; 9(10).

PMID: 36286312 PMC: 9604894. DOI: 10.3390/jcdd9100361.


Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging.

Kitai T, Xanthopoulos A, Nakagawa S, Ishii N, Amano M, Triposkiadis F J Cardiovasc Dev Dis. 2022; 9(6).

PMID: 35735798 PMC: 9224724. DOI: 10.3390/jcdd9060169.